Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment.
Senerchia AA, Macedo CR, Ferman S, Scopinaro M, Cacciavillano W, Boldrini E, Lins de Moraes VL, Rey G, de Oliveira CT, Castillo L, Almeida MT, Borsato ML, Lima E, Lustosa D, Barreto JH, El-Jaick T, Aguiar S, Brunetto A, Greggiani L, Cogo-Moreira H, Atallah A, Petrilli AS. Senerchia AA, et al. Among authors: boldrini e. Cancer. 2017 May 15;123(6):1003-1010. doi: 10.1002/cncr.30411. Epub 2016 Nov 7. Cancer. 2017. PMID: 28263383 Free article. Clinical Trial.
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Brunetto AL, Castillo LA, Petrilli AS, Macedo CD, Boldrini E, Costa C, Almeida MT, Kirst D, Rodriguez-Galindo C, Pereira WV, Watanabe FM, Pizza M, Benites E, Morais V, Gadelha A, Nakasato A, Abujamra AL, Gregianin LJ; Brazilian Collaborative On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors EWING1 and the Brazilian Society of Pediatric Oncology SOBOPE. Brunetto AL, et al. Among authors: boldrini e. Pediatr Blood Cancer. 2015 Oct;62(10):1747-53. doi: 10.1002/pbc.25562. Epub 2015 Apr 27. Pediatr Blood Cancer. 2015. PMID: 25917418 Clinical Trial.
High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
Uzan VR, Lengert Av, Boldrini É, Penna V, Scapulatempo-Neto C, Scrideli CA, Filho AP, Cavalcante CE, de Oliveira CZ, Lopes LF, Vidal DO. Uzan VR, et al. Among authors: boldrini e. PLoS One. 2016 Jun 2;11(6):e0156774. doi: 10.1371/journal.pone.0156774. eCollection 2016. PLoS One. 2016. PMID: 27253450 Free PMC article.
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, Monge OR, Lassaletta A, Boldrini E, Pápai Z, Rubino J, Pathiraja K, Hille DA, Ayers M, Yao SL, Nebozhyn M, Lu B, Mauro D. Anderson PM, et al. Among authors: boldrini e. Pediatr Blood Cancer. 2016 Oct;63(10):1761-70. doi: 10.1002/pbc.26087. Epub 2016 Jun 30. Pediatr Blood Cancer. 2016. PMID: 27362300 Free PMC article. Clinical Trial.
Shorter Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia: The Experience of the Prospective, Randomized Brazilian GBTLI ALL-93 Protocol.
Brandalise SR, Viana MB, Pinheiro VR, Mendonça N, Lopes LF, Pereira WV, Lee ML, Pontes EM, Zouain-Figueiredo GP, Azevedo AC, Pimentel N, Fernandes MZ, Oliveira HM, Vianna SR, Scrideli CA, Werneck FA, Álvares MN, Boldrini É, Loggetto SR, Bruniera P, Mastellaro MJ, Souza EM, Araújo RA, Bandeira F, Tan DM, Carvalho NA, Salgado MA. Brandalise SR, et al. Among authors: boldrini e. Front Pediatr. 2016 Oct 17;4:110. doi: 10.3389/fped.2016.00110. eCollection 2016. Front Pediatr. 2016. PMID: 27800472 Free PMC article.
The Brazilian TP53 mutation (R337H) and sarcomas.
Volc SM, Ramos CRN, Galvão HCR, Felicio PS, Coelho AS, Berardineli GN, Campacci N, Sabato CDS, Abrahao-Machado LF, Santana IVV, Campanella N, Lengert AVH, Vidal DO, Reis RM, Dantas CF, Coelho RC, Boldrini E, Serrano SV, Palmero EI. Volc SM, et al. Among authors: boldrini e. PLoS One. 2020 Jan 24;15(1):e0227260. doi: 10.1371/journal.pone.0227260. eCollection 2020. PLoS One. 2020. PMID: 31978118 Free PMC article.
Insights in Osteosarcoma by Proton Nuclear Magnetic Resonance Serum Metabonomics.
Quintero Escobar M, Costa TBBC, Martins LG, Costa SS, vanHelvoort Lengert A, Boldrini É, Morini da Silva SR, Lopes LF, Vidal DO, Krepischi ACV, Maschietto M, Tasic L. Quintero Escobar M, et al. Among authors: boldrini e. Front Oncol. 2020 Oct 16;10:506959. doi: 10.3389/fonc.2020.506959. eCollection 2020. Front Oncol. 2020. PMID: 33178572 Free PMC article.
71 results